entertainment -WSS

entertainment

author：comprehensive 2025-09-29 01:38:56 - browse：572

Illustration of three connected puzzle pieces, with a woman standing near the missing/empty puzzle piece space. -- first opinion coverage from STAT — Adobe

Women have always been underrepresented in medical research. A new study reveals that not much has changed, especially when it comes to tests of cardiovascular devices.

In a paper published in JAMA Internal Medicine on Monday, researchers found that the percentage of women represented in high-risk medical device trials did not increase from 2010 to 2020. Women generally made up just 33% of participants when the team reviewed 195 trials published from 2016 to 2022. The percentages varied between devices: Women made up 46% of participants in orthopedic trials, but 29% in cardiovascular studies.

The issue isn’t new. The government has made some strides in correcting earlier missteps, like the Food and Drug Administration telling researchers in 1977 to exclude women of reproductive potential from early clinical trials. But stakeholders think agencies like the FDA could do more to incentivize the enrollment of women.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Latest bird flu infection made farmworker sicker than earlier cases

WSS

Readout LOUD podcast: FTC v. biotech, future of Pfizer and Vertex

Akili, maker of video game for ADHD, to be acquired for 34 million

Risky weight loss products often used by teens globally, per study

DeSantis can now import cheaper drugs. But will Biden get credit?

Report: NIH

New Medicare drug pricing powers could soon be upended in court

entertainment

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

knowledge

What does generative AI mean for health care? We asked experts

Readout Newsletter: Insmed, Asahi Kasei, Agios, Royalty Pharma

BioMarin wins approval for gene therapy to treat hemophilia A

New menopause drug shows promise in relief for hot flashes

Walensky prepares to leave CDC — and Congress — behind

Readout LOUD podcast: FTC v. biotech, future of Pfizer and Vertex

United colonoscopy coverage change 'may cost lives,' doctors say

Do more moles mean more problems? Not so, says new study

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Risky weight loss products often used by teens globally, per study

explore

Addiction doctors spar with methadone clinics over legislation

Startling documents reveal new facets of Sacklers' opioid empire

JPM 2024: FogPharma’s CEO unveils ‘contrarian’ plan in oncology

Lab trade group sues FDA to halt regulation of lab

FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

JPM 2024: Verve Therapeutics looks to mainstream genome editing

hotspot

entertainment

entertainment

entertainment